Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Early-life mutagenic exposure to colibactin-producing bacteria may be associated with the increased incidence of early-onset colorectal cancer.

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.